echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Drug review center starts the work of technical review report and drug specification information disclosure

    Drug review center starts the work of technical review report and drug specification information disclosure

    • Last Update: 2016-07-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: CDE 2016-7-18 in accordance with the requirements of the State Council's opinions on the reform of the review and approval system for pharmaceutical and medical devices (GF [2015] No 44), the drug review center launched the technical review report and the disclosure of drug specification information The public technical evaluation report and drug specification will be released to the society through the column of "listed drug information" on CDE website, which can be accessed by all sectors of the society.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.